Nasdaq · CIK 0001826397
AVX AVAX ONE TECHNOLOGY LTD.
Insider trading from SEC Form 4. Last filing Feb 25, 2026. Close $4.79 on Oct 9, 2026, +65% from the 52-week low and -89% from the high.
AVAX ONE TECHNOLOGY LTD. (AVX) has 10 SEC Form 4 filings on file from 9 insiders, the latest filed on Feb 25, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
3 open-market trades have been scored at AVX. The newest: Christopher Vincent Polimeni (Chief Financial Officer) bought $4,375 of stock on Nov 21, 2025, filed Feb 25, 2026, scored 38 (weak). The largest of the 3 shown: Jolie Kahn (Chief Executive Officer) bought $6,650 on Nov 21, 2025, scored 41 (moderate). 2 insiders bought within 14 days of each other around Nov 21, 2025.
AVX closed at $4.79 on Oct 9, 2026, 65% above its 52-week low and 89% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at AVAX ONE TECHNOLOGY LTD., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | Christopher Vincent Polimeni Chief Financial Officer buy | $4,375 2,500 shares | +2% | +15% from low-95% from high | |
| 41Moderate | Jolie Kahn Chief Executive Officer buy | $6,650 4,000 shares | +2% | +15% from low-95% from high | |
| 10Weak | David Ryan Welch director buy | $1,424 11 shares | +0% | - |
Transactions
Every row filed, 19 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 18, 2025 | Christopher Vincent Polimeni Chief Financial Officer | AGrant or award Common Shares | +105,485 | $2.37 | $250k | 105,485 | Feb 25, 2026 |
| Nov 21, 2025 | Christopher Vincent Polimeni Chief Financial Officer | POpen-market purchase Common Shares | +2,500 | $1.75 | $4,375 | 107,985 | Feb 25, 2026 |
| Nov 5, 2025 | Peter John Wylie Jr Chief Operating Officer | AGrant or award Common Stock | +61,224 | $0.00 | $0 | 61,224 | Feb 18, 2026 |
| May 30, 2025 | Jolie Kahn Chief Executive Officer | AGrant or award Common Shares | +15,698 | $13.14 | $206k | 15,698 | Feb 17, 2026 |
| Sep 18, 2025 | Jolie Kahn Chief Executive Officer | AGrant or award Common Shares | +151,899 | $2.39 | $363k | 167,597 | Feb 17, 2026 |
| Nov 21, 2025 | Jolie Kahn Chief Executive Officer | POpen-market purchase Common Shares | +3,000 | $1.65 | $4,950 | 170,597 | Feb 17, 2026 |
| Nov 24, 2025 | Jolie Kahn Chief Executive Officer | POpen-market purchase Common Shares | +1,000 | $1.70 | $1,700 | 171,597 | Feb 17, 2026 |
| Nov 5, 2025 | Jiehua Zhu director | AGrant or award Common Stockindirect: By Kairos Global LLC | +30,612 | $0.00 | $0 | 30,612 | Nov 12, 2025 |
| Nov 5, 2025 | Young Cho director | AGrant or award Common Stock | +30,612 | $0.00 | $0 | 30,612 | Nov 12, 2025 |
| Nov 5, 2025 | Amy Griffith director | AGrant or award Common Shares | +30,612 | $2.45 | $75k | 51,709 | Nov 7, 2025 |
| Nov 5, 2025 | Daniel Mendes director | AGrant or award Common Stock | +30,612 | $0.00 | $0 | 30,612 | Nov 7, 2025 |
| Sep 18, 2025 | Amy Griffith director | AGrant or award Common Shares | +21,097 | $2.37 | $50k | 21,097 | Oct 1, 2025 |
| Sep 12, 2023 | Amy Griffith director | AGrant or award Stock Optionsderivative | +3 | $0.00 | $0 | 5 | Oct 1, 2025 |
| Sep 18, 2025 | David Ryan Welch director | AGrant or award Common Shares | +84,388 | $2.37 | $200k | 97,421 | Sep 30, 2025 |
| Sep 18, 2025 | William John Meekison director | AGrant or award Common Stock | +42,194 | $2.37 | $100k | 42,194 | Sep 30, 2025 |
| May 21, 2025 | David Ryan Welch director | AGrant or award Common Shares | +13,022 | $11.79 | $154k | 97,421 | Sep 30, 2025 |
| Sep 12, 2023 | William John Meekison director | AGrant or award Stock Optionsderivative | +3 | $0.00 | $0 | 4 | Sep 30, 2025 |
| May 17, 2024 | David Ryan Welch director | POpen-market purchase Common Shares | +11 | $129.42 | $1,424 | 97,421 | Sep 30, 2025 |
| Sep 12, 2023 | David Ryan Welch director | AGrant or award Stock Optionsderivative | +3 | $0.00 | $0 | 5 | Sep 30, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Young Chodirector, cfo, officer
- Amy Griffithdirector
- Jolie KahnChief Executive Officer
- William John Meekisondirector
- Daniel Mendesdirector
- Christopher Vincent PolimeniChief Financial Officer
- David Ryan Welchdirector
- Peter John Wylie JrChief Operating Officer
- Jiehua Zhudirector
Questions about AVX
Answered from the filings on this page, as of the latest one.
Are insiders buying AVX?
No. In the last 90 days no insider at AVAX ONE TECHNOLOGY LTD. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade AVX on the open market?
Christopher Vincent Polimeni (Chief Financial Officer) bought $4,375 of AVX on Nov 21, 2025 and filed the Form 4 on Feb 25, 2026. InsiderTell scored 38 (weak), with 2 insiders on the same side within 14 days.
How many insiders file Form 4 at AVAX ONE TECHNOLOGY LTD.?
9 people have filed a Form 4 at AVAX ONE TECHNOLOGY LTD., among them Young Cho (director and CFO), Amy Griffith (director), Jolie Kahn (Chief Executive Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.